Covid-19 vaccination reported side effects and hesitancy among the Syrian population: a cross-sectional study

References

• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):1–14. doi: 10.1016/s0140-6736(20)30183-5.
   PubMed Web of Science ®Google Scholar
• Han E, Tan MMJ, Turk E, et al. Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe. Lancet. 2020;396(10261):1525–1534. doi: 10.1016/s0140-6736(20)32007-9.
   PubMed Web of Science ®Google Scholar
• Farrar c. A race for the covid-19 vaccine: a story of innovation and collaboration 2020 Available from: https://www.carnallfarrar.com/a-race-for-the-covid-19-vaccine-a-story-of-innovation-and-collaboration/. accessed 24 November 2020.
   Google Scholar
• BIO SJASoC-VwWEPEP. Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process WHO2021 [updated 07 July 2022. Available from: https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_07July2022.pdf.
   Google Scholar
• pandem-ic. Mapping our unvaccinated world: pandem-ic; 2022 Available from: https://pandem-ic.com/mapping-our-unvaccinated-world/. accessed September 12, 2022 2022.
   Google Scholar
• Roser HRaEMaLR-GaCAaCGaEO-OaJHaBMaDBaM. Coronavirus Pandemic (COVID-19). 2020. https://ourworldindata.org/covid-vaccinations?country=SYR.
   Google Scholar
• WHO. WHO and Syria combine efforts to raise COVID-19 vaccine accessibility and uptake. 2022. http://www.emro.who.int/syria/news/who-and-syria-combine-efforts-to-raise-covid-19-vaccine-accessibility-and-uptake.html. (accessed 9 Feb 2022).
   Google Scholar
• WHO. Update on COVID-19 vaccination in Syria, 14 June 2021. 2021. http://www.emro.who.int/syria/news/update-on-covid-19-vaccination-in-syria.html. (accessed 14 June 2021).
   Google Scholar
• Prevention CfDCa. Vaccines for COVID-19 Centers for disease control and prevention2022 [Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html. accessed September 16, 2022 2022.
   Google Scholar
• WHO. COVID-19 advice for the public: getting vaccinated: WHO; 2022updated 13 April 2022. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice.
   Google Scholar
• Prevention CfDCa. Possible side effects after getting a COVID-19 vaccine 2022 [updated Aug. 15, 2022. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html#:∼:text=Fever%2C%20headache%2C%20fatigue%2C%20and,are%20. accessed 2022.
   Google Scholar
• WHO. Side effects of COVID-19 vaccines: WHO; 2021 [Available from: https://www.who.int/news-room/feature-stories/detail/side-effects-of-covid-19-vaccines#:∼:text=Common%20side%20effects%20of%20COVID%2D19%20vaccines&text=Reported%20side%20effects%20of%20COVID,muscle%20pain%2C%20chills%20and%20diarrhoea. accessed 31 March 2021.
   Google Scholar
• Ganesan S, Al Ketbi LMB, Al Kaabi N, et al. Vaccine side effects following COVID-19 vaccination among the residents of the UAE-An observational study. Front Public Health. 2022;10:876336. doi: 10.3389/fpubh.2022.876336.
   PubMed Web of Science ®Google Scholar
• worldometers. Coronavirus cases [Available from: https://www.worldometers.info/coronavirus/. accessed September 15, 2022 2020.
   Google Scholar
• Szilagyi PG, Thomas K, Shah MD, et al. The role of trust in the likelihood of receiving a COVID-19 vaccine: results from a national survey. Prev Med. 2021;153:106727. doi: 10.1016/j.ypmed.2021.106727.
   PubMed Web of Science ®Google Scholar
• UK M. Public Lost Confidence in Governments’ Handling of COVID Over Time: Survey: Medscape UK; 2022 [updated September 15, 2022. Available from: https://www.medscape.co.uk/viewarticle/public-lost-confidence-governments-handline-covid-over-time-2022a1001s3v. accessed July 12, 2022.
   Google Scholar
• Tran BX, Boggiano VL, Nguyen LH, et al. Media representation of vaccine side effects and its impact on utilization of vaccination services in Vietnam. Patient Prefer Adherence. 2018;12:1717–1728. doi: 10.2147/ppa.S171362.
   PubMed Web of Science ®Google Scholar
• Cascini F, Pantovic A, Al-Ajlouni YA, et al. Social media and attitudes towards a COVID-19 vaccination: a systematic review of the literature. EClinicalMedicine. 2022;48:101454. doi: 10.1016/j.eclinm.2022.101454.
   PubMedGoogle Scholar
• Prevention CfDCa. Possible Side Effects After Getting a COVID-19 Vaccine: Centers for Disease Control and Prevention; 2022 [updated Sept. 14, 2022. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html. accessed September 16, 2022.
   Google Scholar
• Nomura S, Yoneoka D, Shi S, et al. An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: has the regional risk changed after the declaration of the state of emergency? Lancet Reg Health West Pac. 2020;1:100011. doi: 10.1016/j.lanwpc.2020.100011.
   PubMedGoogle Scholar
• Adorni F, Prinelli F, Bianchi F, et al. Self-reported symptoms of SARS-CoV-2 infection in a nonhospitalized population in Italy: cross-sectional study of the EPICOVID19 web-based survey. JMIR Public Health Surveill. 2020;6(3):e21866. doi: 10.2196/21866.
   PubMedGoogle Scholar
• Pormohammad A, Zarei M, Ghorbani S, et al. Efficacy and safety of COVID-19 vaccines: a systematic review and meta-analysis of randomized clinical trials. Vaccines. 2021;9(5):467. doi: 10.3390/vaccines9050467.
   Web of Science ®Google Scholar
• Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021;9(2):160. doi: 10.3390/vaccines9020160.
   Web of Science ®Google Scholar
• Simione L, Vagni M, Gnagnarella C, et al. Mistrust and beliefs in conspiracy theories differently mediate the effects of psychological factors on propensity for COVID-19 vaccine. Front Psychol. 2021;12:683684. doi: 10.3389/fpsyg.2021.683684.
   PubMed Web of Science ®Google Scholar
• Robertson E, Reeve KS, Niedzwiedz CL, et al. Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain Behav Immun. 2021;94:41–50. doi: 10.1016/j.bbi.2021.03.008.
   PubMed Web of Science ®Google Scholar
• Lucia VC, Kelekar A, Afonso NM. COVID-19 vaccine hesitancy among medical students. J Public Health. 2021;43(3):445–449. doi: 10.1093/pubmed/fdaa230.
   Web of Science ®Google Scholar
• Swed S, Baroudi I, Ezzdean W, et al. COVID-19 vaccine hesitancy among people in syria: an incipient crisis. Ann Med Surg. 2022;75:103324. doi: 10.1016/j.amsu.2022.103324.
   PubMed Web of Science ®Google Scholar
• Mohamad O, Zamlout A, AlKhoury N, et al. Factors associated with the intention of syrian adult population to accept COVID19 vaccination: a cross-sectional study. BMC Public Health. 2021;21(1):1310. doi: 10.1186/s12889-021-11361-z.
   PubMed Web of Science ®Google Scholar
• Bekele F, Fekadu G, Wolde TF, et al. Patients’ acceptance of COVID-19 vaccine: implications for patients with chronic disease in low-resource settings. Patient Prefer Adherence. 2021;15:2519–2521. doi: 10.2147/ppa.S341158.
   PubMed Web of Science ®Google Scholar
• El-Elimat T, AbuAlSamen MM, Almomani BA, et al. Acceptance and attitudes toward COVID-19 vaccines: a cross-sectional study from Jordan. PLOS One. 2021;16(4):e0250555. doi: 10.1371/journal.pone.0250555.
   PubMed Web of Science ®Google Scholar
• Shekhar R, Sheikh AB, Upadhyay S, et al. COVID-19 vaccine acceptance among health care workers in the United States. Vaccines. 2021;9(2):119. doi: 10.3390/vaccines9020119.
   Web of Science ®Google Scholar
• Alhazmi A, Alamer E, Daws D, et al. Evaluation of side effects associated with COVID-19 vaccines in Saudi Arabia. Vaccines. 2021;9(6):674. doi: 10.3390/vaccines9060674.
   Web of Science ®Google Scholar
• Almufty HB, Mohammed SA, Abdullah AM, et al. Potential adverse effects of COVID19 vaccines among iraqi population; a comparison between the three available vaccines in Iraq; a retrospective cross-sectional study. Diabetes Metab Syndr. 2021;15(5):102207. doi: 10.1016/j.dsx.2021.102207.
   PubMed Web of Science ®Google Scholar
• Riad A, Pokorná A, Attia S, et al. Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. J Clin Med. 2021;10(7):1428. doi: 10.3390/jcm10071428.
   Web of Science ®Google Scholar
• Menni C, Klaser K, May A, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID symptom study app in the UK: a prospective observational study. Lancet Infect Dis. 2021;21(7):939–949. doi: 10.1016/s1473-3099(21)00224.
   PubMed Web of Science ®Google Scholar
• Hatmal MM, Al-Hatamleh MAI, Olaimat AN, et al. Side effects and perceptions following COVID-19 vaccination in Jordan: a randomized, cross-sectional study implementing machine learning for predicting severity of side effects. Vaccines. 2021;9(6):556. doi: 10.3390/vaccines9060556.
   Web of Science ®Google Scholar
• Cohen DA, Greenberg P, Formanowski B, et al. Are COVID-19 mRNA vaccine side effects severe enough to cause missed work? Cross-sectional study of health care-associated workers. Medicine. 2022;101(7):e28839. doi: 10.1097/md.0000000000028839.
   PubMed Web of Science ®Google Scholar
• Konu YR, Gbeasor-Komlanvi FA, Yerima M, et al. Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021. Arch Public Health. 2021;79(1):207. doi: 10.1186/s13690-021-00741-x.
   PubMed Web of Science ®Google Scholar
• Beatty AL, Peyser ND, Butcher XE, et al. Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Netw Open. 2021;4(12):e2140364. doi: 10.1001/jamanetworkopen.2021.40364.
   PubMed Web of Science ®Google Scholar
• Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403–416. doi: 10.1056/NEJMoa2035389.
   PubMed Web of Science ®Google Scholar
• Mahase E. Covid-19: AstraZeneca vaccine is not linked to increased risk of blood clots, finds European medicine agency. BMJ. 2023;380:741. doi: 10.1136/bmj.n774.
   PubMedGoogle Scholar
• Wise J. Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots. BMJ. 2021;372:n699. doi: 10.1136/bmj.n699.
   PubMed Web of Science ®Google Scholar
• Kuter DJ. Exacerbation of immune thrombocytopenia following COVID-19 vaccination. Br J Haematol. 2021;195(3):365–370. doi: 10.1111/bjh.17645.
   PubMed Web of Science ®Google Scholar
• Mathioudakis AG, Ghrew M, Ustianowski A, et al. Self-reported real-world safety and reactogenicity of COVID-19 vaccines: a vaccine recipient survey. Life. 2021;11(3):249. doi: 10.3390/life11030249.
   Google Scholar
• Assiri SA, Althaqafi RMM, Alswat K, et al. Post COVID-19 Vaccination-Associated neurological complications. Neuropsychiatr Dis Treat. 2022;18:137–154. doi: 10.2147/ndt.S343438.
   PubMed Web of Science ®Google Scholar
• Maadarani O, Bitar Z, Elzoueiry M, et al. Myocardial infarction post COVID-19 vaccine - coincidence, kounis syndrome or other explanation - time will tell. JRSM Open. 2021;12(8):20542704211025259. doi: 10.1177/20542704211025259.
   Google Scholar
• Ossato A, Tessari R, Trabucchi C, et al. Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (comirnaty, Pfizer-BioNTech) vaccine: a post-marketing italian study conducted between 1 january and 28 february 2021. Eur J Hosp Pharm. 2023;30(4):e15. doi: 10.1136/ejhpharm-2021-002933.
   PubMedGoogle Scholar
• Camacho Moll ME, Salinas Martínez AM, Tovar Cisneros B, et al. Extension and severity of self-reported side effects of seven COVID-19 vaccines in mexican population. Front Public Health. 2022;10:834744. doi: 10.3389/fpubh.2022.834744.
   PubMed Web of Science ®Google Scholar
• Ahamad MM, Aktar S, Uddin MJ, et al. Adverse effects of COVID-19 vaccination: machine learning and statistical approach to identify and classify incidences of morbidity and post-vaccination reactogenicity. Healthcare (Basel). 2022;11(1):31. DOI:10.3390/healthcare11010031
   Google Scholar
• Kelso JM. Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines. Vaccine. 2021;39(6):865–867. doi: 10.1016/j.vaccine.2020.12.084.
   PubMed Web of Science ®Google Scholar
• Ramos CL, Kelso JM. COVID arm’: very delayed large injection site reactions to mRNA COVID-19 vaccines. J Allergy Clin Immunol Pract. 2021;9(6):2480–2481. doi: 10.1016/j.jaip.2021.03.055.
   PubMed Web of Science ®Google Scholar
• Wei N, Fishman M, Wattenberg D, et al. COVID arm’: a reaction to the moderna vaccine. JAAD Case Rep. 2021;10:92–95. doi: 10.1016/j.jdcr.2021.02.014.
   PubMedGoogle Scholar
• Patone M, Mei XW, Handunnetthi L, et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med. 2022;28(2):410–422. doi: 10.1038/s41591-021-01630-0.
   PubMed Web of Science ®Google Scholar
• Muhaidat N, Alshrouf MA, Azzam MI, et al. Menstrual symptoms after COVID-19 vaccine: a cross-sectional investigation in the MENA region. Int J Womens Health. 2022;14:395–404. doi: 10.2147/ijwh.S352167.
   PubMed Web of Science ®Google Scholar
• Laganà AS, Veronesi G, Ghezzi F, et al. Evaluation of menstrual irregularities after COVID-19 vaccination: results of the MECOVAC survey. Open Med. 2022;17(1):475–484. doi: 10.1515/med-2022-0452.
   Web of Science ®Google Scholar
• Subramanian SV, Kumar A. Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States. Eur J Epidemiol. 2021;36(12):1237–1240. doi: 10.1007/s10654-021-00808-7.
   PubMed Web of Science ®Google Scholar
• Suah JL, Husin M, Tok PSK, et al. Waning COVID-19 vaccine effectiveness for BNT162b2 and CoronaVac in Malaysia: an observational study. Int J Infect Dis. 2022;119:69–76. doi: 10.1016/j.ijid.2022.03.028.
   PubMed Web of Science ®Google Scholar
• AlQahtani M, Du X, Bhattacharyya S, et al. Post-vaccination outcomes in association with four COVID-19 vaccines in the om of Bahrain. Sci Rep. 2022;12(1):9236. doi: 10.1038/s41598-022-12543-4.
   PubMed Web of Science ®Google Scholar
• Klugar M, Riad A, Mekhemar M, et al. Side effects of mRNA-Based and viral Vector-Based COVID-19 vaccines among german healthcare workers. Biology. 2021;10(8):752. doi: 10.3390/biology10080752.
   PubMedGoogle Scholar
• Lounis M, Rais MA, Bencherit D, et al. Side effects of COVID-19 inactivated virus vs. Adenoviral vector vaccines: experience of Algerian healthcare workers. Front Public Health. 2022;10:896343. doi: 10.3389/fpubh.2022.896343.
   PubMed Web of Science ®Google Scholar
• Wu Q, Dudley MZ, Chen X, et al. Evaluation of the safety profile of COVID-19 vaccines: a rapid review. BMC Med. 2021;19(1):173. doi: 10.1186/s12916-021-02059-5.
   PubMed Web of Science ®Google Scholar
• Dadras O, Mehraeen E, Karimi A, et al. Safety and adverse events related to inactivated COVID-19 vaccines and novavax;a systematic review. Arch Acad Emerg Med. 2022;10(1):e54. doi: 10.22037/aaem.v10i1.1585.
   PubMedGoogle Scholar
• Zheng C, Shao W, Chen X, et al. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. Int J Infect Dis. 2022;114:252–260. doi: 10.1016/j.ijid.2021.11.009.
   PubMed Web of Science ®Google Scholar